Moderna faces significant uncertainty ahead of Q3 earnings, with heavy reliance on COVID vaccine revenues and limited ...

Attempting to cash in on what's likely to be a relatively short-lived mania isn't a good idea for most investors most of the ...

Ginkgo Bioworks Holdings, Inc. (DNA) ended the recent trading session at $15.12, demonstrating a -4.49% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a ...

Dr Natalie Crawford explained how weed can sometimes scupper your chances of starting a family and what men can do to boost ...

In a serious lapse that could have endangered patient safety, the Regional Cancer Centre (RCC) in Thiruvananthapuram has ...

Sebi chairman called upon PIDs of market infrastructure institutions to act as “custodians of trust” and to place public ...

Regenerative medicine is a fast-growing field harnessing the body’s natural healing ability and has become a focus for several ASX biotechs.

Ferrari’s leap into electrification tests whether its luxury brand – built on roaring engines and racing heritage – can ...

Grail (NASDAQ: GRAL), a healthcare company focused on multi-cancer early detection, saw its shares surge more than 14% on ...

Moderna, Inc. remains under pressure in 2025, despite recent next-gen COVID vaccine approval & cancer vaccine trial. Learn ...

On Friday, Sept. 26, Applied DNA Sciences Inc. shares abruptly soared as much as 52%.